Putative Transcriptomic Biomarkers in the Inflammatory Cytokine Pathway Differentiate Major Depressive Disorder Patients from Control Subjects and Bipolar Disorder Patients

The inflammatory cytokines: molecular biomarkers for major depressive disorder?

(2015) Charlotte Martin et al.   Biomarkers in Medicine

Mood-stabilizers differentially affect housekeeping gene expression in human cells

(2014) Timothy R. Powell et al.   INTERNATIONAL JOURNAL OF METHODS IN PSYCHIATRIC RESEARCH

ATP-binding cassette sub-family F member 1 (ABCF1) is identified as a putative therapeutic target of escitalopram in the inflammatory cytokine pathway

(2013) Timothy R Powell et al.   JOURNAL OF PSYCHOPHARMACOLOGY

A meta-analysis of differences in IL-6 and IL-10 between people with and without depression: Exploring the causes of heterogeneity

(2012) Sarah A. Hiles et al.   BRAIN BEHAVIOR AND IMMUNITY

Life-event specificity: bipolar disorder compared with unipolar depression

(2012) Georgina M. Hosang et al.   BRITISH JOURNAL OF PSYCHIATRY

Tumor necrosis factor and its targets in the inflammatory cytokine pathway are identified as putative transcriptomic biomarkers for escitalopram response

(2012) Timothy R. Powell et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Can bipolar disorder be viewed as a multi-system inflammatory disease?

(2012) Marion Leboyer et al.   JOURNAL OF AFFECTIVE DISORDERS

Interaction between specific forms of childhood maltreatment and the serotonin transporter gene (5-HTT) in recurrent depressive disorder

(2012) Helen L. Fisher et al.   JOURNAL OF AFFECTIVE DISORDERS

Candidate Genes Expression Profile Associated with Antidepressants Response in the GENDEP Study: Differentiating between Baseline ‘Predictors’ and Longitudinal ‘Targets’

(2012) Annamaria Cattaneo et al.   NEUROPSYCHOPHARMACOLOGY

Low vascular endothelial growth factor and interleukin-8 in cerebrospinal fluid of suicide attempters

(2012) J Isung et al.   Translational Psychiatry

Interleukin (IL)-6, tumour necrosis factor alpha (TNF-α) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: A meta-analysis and meta-regression

(2011) Yang Liu et al.   JOURNAL OF AFFECTIVE DISORDERS

Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4

(2011)   NATURE GENETICS

Gene–Environment Interaction in Major Depression and Antidepressant Treatment Response

(2011) Robert Keers et al.   Current Psychiatry Reports

The Bipolar Association Case-Control Study (BACCS) and meta-analysis: No association with the 5,10-Methylenetetrahydrofolate reductase gene and bipolar disorder

(2010) Sarah Cohen-Woods et al.   AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS

Genome-Wide Pharmacogenetics of Antidepressant Response in the GENDEP Project

(2010) Rudolf Uher et al.   AMERICAN JOURNAL OF PSYCHIATRY

Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression

(2009) Andrew H. Miller et al.   BIOLOGICAL PSYCHIATRY

Serum chemokine levels in major depressive disorder

(2009) Soili M. Lehto et al.   PSYCHONEUROENDOCRINOLOGY

A Discriminating Messenger RNA Signature for Bipolar Disorder Formed by an Aberrant Expression of Inflammatory Genes in Monocytes

(2008) Roos C. Padmos et al.   ARCHIVES OF GENERAL PSYCHIATRY

Influence of Child Abuse on Adult Depression

(2008) Rebekah G. Bradley et al.   ARCHIVES OF GENERAL PSYCHIATRY

A detailed examination of cytokine abnormalities in Major Depressive Disorder

(2007) N.M. Simon et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY